PerkinElmer Genomics accepts all in-network insurances for the majority of our clinical testing menu. PerkinElmer Genomics provides transparent communication regarding associated testing costs and a generous patient assistance plan. These are just some of the ways that we are increasing access to testing and helping patients, and their families, reach a diagnosis.

Our Commercial Insurance Billing Policy

  • PerkinElmer Genomics will submit an insurance claim on behalf of any patient with in-network commercial insurance coverage.
  • Patients may be responsible for any portion of the test fee not covered by the insurance company for any reason including, but not limited to, co-payments, co-insurance, unmet deductibles, or non-covered services.
  • Please see our full Benefits Investigation and Out-of-Pocket Cost Policy below.
  • In addition to commercial insurance billing, we offer a Patient (Self) Payment option for patients that prefer not to submit a claim through their insurance plan and a patient assistance program to help in-network commercial patients with higher out-of-pocket costs.
  • For more information about PerkinElmer Genomics’ patient assistance program, contact helpme@perkinelmer.com
  • At this time, some of our tests are not eligible for insurance billing, including, but not limited to whole genome sequencing and STAT testing options.

Benefit Investigation and Out-of-Pocket Cost Policy

  • A benefit investigation will be performed for all patients requesting insurance billing.
  • PerkinElmer Genomics will contact the patient with any estimated out-of-pocket (OOP) costs that are greater than $100 USD before proceeding with testing.
  • Testing will not start until the patient approves the estimated OOP costs.
  • The patient’s sample will be placed on hold (for up to 30 days) until authorization to proceed is received from the patient. If the patient does not respond to PerkinElmer within 30 days to discuss estimated out-of-pocket costs, the test order may be cancelled.
    • Please note that failure by the patient to respond to PerkinElmer in a timely fashion regarding estimated out-of-pocket costs may cause a delay in the receipt of test results.
  • For patients with in-network insurance, any quoted OOP cost during the benefit investigation process will be honored to the patient throughout the billing process assuming there are no changes to the patient’s coverage prior to the time of result reporting.
  • Patients with out-of-network insurance will be offered billing via the patient (self) payment option.

Prior Authorization Information

  • Many health plans require a prior authorization and/or documentation of appropriate genetic counseling before genetic testing can be performed. It is important that an independent genetic counselor provide this pre-test counseling to patients. PerkinElmer Genomics can facilitate the release of patient information to an independent third party for this purpose. Alternatively, to locate a genetic counselor in your area, please visit www.nsgc.org.
  • PerkinElmer Genomics offers the ability to facilitate the prior authorization on the physician’s behalf. This only requires a simple two-step process to complete the required documentation. Contact us today to learn more.

Medicare & Medicaid Billing Policy

PerkinElmer Genomics currently accepts select Medicaid and Medicare Advantage plans. To inquire whether Medicaid is currently accepted in your state, or information about a specific plan, please email us at helpme@perkinelmer.com.

Contact Us to Learn More

Any questions or concerns regarding insurance billing can be submitted via helpme@perkinelmer.com or by calling 844-956-1179. For patient or institutional billing inquiries, contact perkinelmergenetics.billing@perkinelmer.com or call 877-475-4436.

FAQS

PKIG will file an insurance claim on behalf of the patient with any in-network insurance company.

PerkinElmer Genomics is frequently adding to our list of in-network insurance plans. Since we will not process out-of-network insurance, any patient with an out-of-network plan will be notified, prior to starting testing, with the option to convert their billing to Patient (Self) Payment. Clinicians may also request a benefits investigation prior to submitting the sample here: https://apps.perkinelmergenomics.com/pre-bi/

  • PerkinElmer Genomics currently accepts Medicaid policies from select states across the United States. To inquire whether Medicaid is currently accepted for your state, please email us at helpme@perkinelmer.com.
  • PerkinElmer Genomics participates with select Medicare Advantage plans. Contact helpme@perkinelmer.com for additional information.
  • The Insurance Billing section on the test requisition form captures the information needed for insurance billing. This section must be completed in its entirety, including patient signature, before testing can begin.
  • Additional information may be requested to fully process a claim, such as pertinent medical record information, and/or a letter of medical necessity.
  • PKIG can assist with a benefits investigation prior to submitting an order. To determine potential insurance coverage. Visit https://apps.perkinelmergenomics.com/pre-bi/ to submit a benefits investigation request.
  • A benefits investigation does not guarantee coverage or payment.
  • Any OOP cost quoted during the benefits investigation process will be honored throughout the billing process, assuming there are no changes to the patient’s coverage prior to the time of result reporting, and a complete order for the test code quoted, and the respective sample submission, are received within 45 days of the quote.
  • PerkinElmer will contact the patient with any estimated out-of-pocket (OOP) costs that are greater than $100 USD before proceeding with testing. Testing will not start until the patient approves the estimated OOP costs. The patient’s sample will be placed on hold (for up to 30 days) until authorization to proceed is received from the patient. If the patient does not respond to PerkinElmer within 30 days to discuss estimated out-of-pocket costs, the test order may be cancelled.
    • For patients with in-network insurance, any quoted OOP cost during the benefit investigation process will be honored to the patient throughout the billing process assuming there are no changes to the patient’s coverage prior to the time of result reporting.
    • Patients with out-of-network insurance will be contacted and offered billing via the patient pay option.
  • Payment is not required until the insurance claim is fully processed and has an adjudicated outcome. At this time a statement will be sent to the patient reflecting the amount due.
  • Patients are responsible for remitting to PerkinElmer Genomics any funds received directly from the insurance company.
  • Preauthorization does not guarantee payment. Exact coverage for genetic testing is determined by the details of the patient’s health insurance plan and can vary by insurance provider and employer.
  • The patient may be responsible for any portion of the test fee not covered by the insurance company for any reason including, but not limited to, co-payments, co-insurance, unmet deductibles, or non-covered services.

An EOB is not a bill. An EOB is a document from your insurance company describing how your plan covers a test or service, and how much of the associated fees are paid for by your plan. An EOB will show if there is any additional amount not covered, for which you may be responsible, but is not a bill and is not necessarily the amount you will owe. The EOB typically precedes your bill. The billing statement will come from PerkinElmer and will identify the out-of-pocket responsibility owed.

Patients have the option to pay their outstanding balance online at www.mylabbill.com or by calling our billing department at 1-844-956-1179 between 9 AM EST – 7 PM EST.

  • PerkinElmer Genomics offers two alternatives to commercial insurance billing. The first option is Institutional Billing where the ordering/provider institution is responsible for the cost of testing and an invoice is sent directly to them. The second option is Patient (Self) Pay where the patient chooses to pay directly for the test as opposed to submitting a commercial insurance claim.
  • Please note: An insurance claim cannot be submitted if Patient Pay or Institutional Billing is selected.
  • Yes, PKIG will not begin testing until payment is received. PKIG accepts Visa, MasterCard, and Discover.
  • Payment can also be remitted via personal check.
  • If the Patient Pay billing option is selected, a member of our finance team will reach out to the patient to collect payment if payment information was not submitted at the time of the order.
  • Any questions or concerns regarding patient billing can be submitted via perkinelmergenetics.billing@perkinelmer.com or by calling 877-475-4436.

PKIG’s Tax Identification Number is 25-1645804.

PKIG’s NPI Number is 18-71585067.

An order can be cancelled if test processing has not begun. Once the test process starts, testing cannot be cancelled. If you need a cancel a test, please contact our customer service team at genomics@perkinelmer.com.

Many health plans require a prior authorization and/or documentation of appropriate genetic counseling before genetic testing can be performed. It is important that an independent genetic counselor provide this pre-test counselling to patients. PerkinElmer Genomics can facilitate the release of patient information to an independent third party for this purpose. Alternatively, to locate a genetic counselor in your area, please visit www.nsgc.org.

Please contact our billing department at 1-844-956-1179 between 8 AM EST – 8 PM EST, or email helpme@perkinelmer.com, with questions about insurance-related genetic counseling requirements.